Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

General blockade of human cytomegalovirus immediate-early mRNA expression in the S/G2 phase by a nuclear, Daxx- and PML-independent mechanism.

Zydek M, Uecker R, Tavalai N, Stamminger T, Hagemeier C, Wiebusch L.

J Gen Virol. 2011 Dec;92(Pt 12):2757-69. doi: 10.1099/vir.0.034173-0. Epub 2011 Aug 10.

PMID:
21832009
2.

Evidence for a dual antiviral role of the major nuclear domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle.

Tavalai N, Adler M, Scherer M, Riedl Y, Stamminger T.

J Virol. 2011 Sep;85(18):9447-58. doi: 10.1128/JVI.00870-11. Epub 2011 Jul 6.

3.

Human cytomegalovirus immediate-early gene expression is restricted by the nuclear domain 10 component Sp100.

Adler M, Tavalai N, M├╝ller R, Stamminger T.

J Gen Virol. 2011 Jul;92(Pt 7):1532-8. doi: 10.1099/vir.0.030981-0. Epub 2011 Apr 6.

PMID:
21471311
4.

Intrinsic cellular defense mechanisms targeting human cytomegalovirus.

Tavalai N, Stamminger T.

Virus Res. 2011 May;157(2):128-33. doi: 10.1016/j.virusres.2010.10.002. Epub 2010 Oct 8. Review.

PMID:
20934469
5.

Interplay between Herpesvirus Infection and Host Defense by PML Nuclear Bodies.

Tavalai N, Stamminger T.

Viruses. 2009 Dec;1(3):1240-64. doi: 10.3390/v1031240. Epub 2009 Dec 15.

6.

Importance of covalent and noncovalent SUMO interactions with the major human cytomegalovirus transactivator IE2p86 for viral infection.

Berndt A, Hofmann-Winkler H, Tavalai N, Hahn G, Stamminger T.

J Virol. 2009 Dec;83(24):12881-94. doi: 10.1128/JVI.01525-09. Epub 2009 Oct 7.

7.

New insights into the role of the subnuclear structure ND10 for viral infection.

Tavalai N, Stamminger T.

Biochim Biophys Acta. 2008 Nov;1783(11):2207-21. doi: 10.1016/j.bbamcr.2008.08.004. Epub 2008 Aug 16. Review.

8.

Insertion of an EYFP-pp71 (UL82) coding sequence into the human cytomegalovirus genome results in a recombinant virus with enhanced viral growth.

Tavalai N, Kraiger M, Kaiser N, Stamminger T.

J Virol. 2008 Nov;82(21):10543-55. doi: 10.1128/JVI.01006-08. Epub 2008 Aug 20.

9.

Proteasome inhibitor MG132 blocks viral DNA replication and assembly of human cytomegalovirus.

Kaspari M, Tavalai N, Stamminger T, Zimmermann A, Schilf R, Bogner E.

FEBS Lett. 2008 Mar 5;582(5):666-72. doi: 10.1016/j.febslet.2008.01.040. Epub 2008 Jan 31.

11.

Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells.

Sourvinos G, Tavalai N, Berndt A, Spandidos DA, Stamminger T.

J Virol. 2007 Sep;81(18):10123-36. Epub 2007 Jul 11.

12.
13.

PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0.

Everett RD, Rechter S, Papior P, Tavalai N, Stamminger T, Orr A.

J Virol. 2006 Aug;80(16):7995-8005.

14.

Deletion of open reading frame UL26 from the human cytomegalovirus genome results in reduced viral growth, which involves impaired stability of viral particles.

Lorz K, Hofmann H, Berndt A, Tavalai N, Mueller R, Schl├Âtzer-Schrehardt U, Stamminger T.

J Virol. 2006 Jun;80(11):5423-34.

Supplemental Content

Loading ...
Support Center